ArticleFrontiers in immunology2026

An anoikis-related gene signature predicts prognosis and immunotherapy response, and identifies CCAR2 as a therapeutic target in triple-negative breast cancer.

Yan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.